Alignment on potency assays is the critical one for me. That had the potential to blow out approval for a long time given it is a differently differentiated MSC to Rynoncil.
- Forums
- ASX - By Stock
- Ann: Mesoblast Maintains Momentum with FDA
MSB
mesoblast limited
Add to My Watchlist
1.35%
!
$1.65

Alignment on potency assays is the critical one for me. That had...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
-0.023(1.35%) |
Mkt cap ! $2.098B |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.62 | $6.161M | 3.757M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 48365 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.65 | 17598 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 50316 | 1.640 |
12 | 53528 | 1.635 |
12 | 83731 | 1.630 |
11 | 138361 | 1.625 |
13 | 118194 | 1.620 |
Price($) | Vol. | No. |
---|---|---|
1.645 | 82416 | 33 |
1.650 | 21264 | 22 |
1.655 | 69686 | 19 |
1.660 | 76173 | 16 |
1.665 | 105270 | 7 |
Last trade - 13.26pm 20/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |